Previous 10 | Next 10 |
CASI Pharmaceuticals, Inc. (CASI) Q2 2020 Results Conference Call August 10, 2020 04:30 PM ET Company Participants Cynthia Hu - General Counsel & Secretary Dr. Wei-Wu He - Chairman and CEO Dr. Alex Zukiwski - Chief Medical Officer Conference Call Participants Nathaniel ...
CASI Pharmaceuticals (NASDAQ: CASI ) : Q2 GAAP EPS of -$0.09 misses by $0.01 . More news on: CASI Pharmaceuticals, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...
ROCKVILLE, Md. and BEIJING , Aug. 10, 2020 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today reported financial results and business highligh...
ROCKVILLE, Md. and BEIJING , Aug. 3, 2020 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today announced the Company will host a conference...
Deals and Financing Beijing's BeiGene (NSDQ: [[BGNE]]; HK: 06160) in-licensed Greater China rights to three inhibitors for chronic hepatitis B virus ((HBV)) from Assembly Biosciences (NSDQ: [[ASMB]]) in a $540 million agreement. All three molecules have started US clinical trials. BeiGen...
CASI Pharmaceuticals (NASDAQ: CASI ) is up 11.9% after hours following news that its Chairman/CEO, Wei-Wu He, bought nearly $7.9M worth of the company's stock. More news on: CASI Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Read more ...
CASI Pharmaceuticals ( CASI -12.3% ) prices its public offering of 20M at $1.90/share, for gross proceeds of $38M. More news on: CASI Pharmaceuticals, Inc., Healthcare stocks news, , Stocks on the move, Read more ...
ROCKVILLE, Md. and BEIJING , July 22, 2020 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today announced the pricing of an underwritten publi...
CASI Pharmaceuticals (NASDAQ: CASI ) -10.3% AH announced that it has commenced an underwritten public offering to issue and sell shares of its common stock with a 30-day underwriter option to purchase up to an additional 15% of the shares. More news on: CASI Pharmaceut...
ROCKVILLE, Md. and BEIJING , July 21, 2020 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today announced that it has commenced an underwritte...
News, Short Squeeze, Breakout and More Instantly...
CASI Pharmaceuticals Inc. Company Name:
CASI Stock Symbol:
NASDAQ Market:
CASI Pharmaceuticals Inc. Website:
2024-07-17 13:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
CASI Pharmaceuticals announces appointment of Daniel Lang, MD as CFO and SVP PR Newswire BEIJING , July 8, 2024 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a Cayman incorporated biopharmaceutical company focused on developing and commercializing in...
A look at the top 10 most actives in the United States Faraday Future Intelligent Electric Inc. (FFIE) rose 30.9% to $0.6 on volume of 558,931,853 shares NVIDIA Corporation (NVDA) fell 1.9% to $123.99 on volume of 249,243,816 shares Assure Holdings Corp. (IONM) rose 82.8% to $0.424 on vol...